Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Complete Response Letter
Biotech
Vanda sues FDA over months-long hearing delay
Vanda says CDER “has asked the commissioner to allow it to take six months to merely respond to Vanda’s request for a hearing."
Gabrielle Masson
Apr 23, 2025 10:33am
Aldeyra’s dry eye drug suffers second FDA rejection
Apr 3, 2025 8:46am
FDA hits Zealand Pharma's Gattex challenger with CRL
Dec 19, 2024 4:22pm
FDA rejects Applied filing for rare disease approval
Dec 2, 2024 5:27am
Vanda receives FDA rejection, issues fiery response
Sep 19, 2024 8:02am
FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer
Aug 21, 2024 5:48am